Physician profile
Lauren E Smith
NPI 1811202146
$1,203.68
in general payments reported to CMS, 2019-2025
12 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $70.26 · 2023: $453 · 2024: $216 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.12 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $368.41 | 2023-2025 | Jakafi, Monjuvi, Pemazyre |
| Myriad Genetic Laboratories, INC. | $288.43 | 2023 | Myrisk |
| Endo Pharmaceuticals INC. | $146.92 | 2021 | |
| Karyopharm Therapeutics INC. | $111.31 | 2023-2025 | Xpovio |
| Boston Scientific Corporation | $53.85 | 2022 | |
| Gilead Sciences, INC. | $50.30 | 2023-2024 | Trodelvy |
| Abbott Laboratories | $48.43 | 2024-2025 | Ensite, Xience Skypoint |
| Janssen Biotech, INC. | $40.80 | 2024-2025 | Talvey, Tecvayli, Darzalex |
| Astellas Pharma US INC | $38.69 | 2021 | |
| Pfizer INC. | $23.39 | 2024 | |
| Stryker Corporation | $16.74 | 2021 | |
| Merck Sharp & Dohme LLC | $16.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.